March 20, 2006
New Vaccine will not meet deadline
25. March 17, XXXXXXX XXXX — Anthrax vaccine won't meet deadline. The government's effort to develop a new anthrax vaccine has run into difficulty, with the company in charge of the project reporting failure in a major human test and falling at least a year behind schedule.
Officers at VaxGen Inc. of Brisbane, CA, said in interviews that they believe they have isolated the problem with their vaccine and are well on their way to fixing it. But they acknowledged that they have no hope of meeting a deadline to deliver 25 million doses of the vaccine into a national stockpile by November and will default on their contract with the government unless it grants an extension they have requested. Until the full stockpile of 75 million doses is ready, the U.S. would depend on antibiotics to treat a large−scale anthrax attack, a strategy that terrorists could overcome by creating antibiotic−resistant anthrax.
Posted by hspigorg at March 20, 2006 07:25 AM
Post a comment
Thanks for signing in, . Now you can comment. (sign out)(If you haven't left a comment here before, you may need to be approved by the site owner before your comment will appear. Until then, it won't appear on the entry. Thanks for waiting.)